EQS-News

Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe - Seite 2

About GAIA Healthcare FZ LLC

Gaia Healthcare was established in 2016 to address unmet medical needs in the Gulf Region with the aim of bringing pharmaceutical products & services using a European model of techno-driven pharmaceutical distribution with first mover advantage in the United Arab Emirates & nearby Gulf Countries. Over the last 3 years, GAIA has associated with some of the prestigious European & Asian Pharmaceutical Manufacturers. GAIA has launched several Innovators, Innovator Pharmaceutical, first to file generics, Value added Generics, differentiated generics, medical devices with clinical Innovation, Several OTC Products which will definitely help patients, clinicians and pharmacist community in the region.

About VitaPlus Kft.

VitaPlus is a leading Hungarian pharmaceutical company active in the development and distribution of innovative and value-for-money branded food supplements and medical devices in Hungary and beyond. VitaPlus brands such as 1x1 Vitamin, Innopharm and Medistus are well known by Hungarian pharmacists and consumers and very visible in the Hungarian pharmacies, drugstores and food chains. In 2022, VitaPlus achieved a turnover of EUR 9 million. VitaPlus is part of the Belgium based Ceres Pharma Group active in 10 countries in Europe with 600 employees and EUR 140 million turn over.

About Carragelose

Carragelose is a sulfated polymer from red seaweed and a unique, broadly active virus-blocking compound. It is known as a gentle, effective, and safe prevention and treatment of various viral respiratory infections. Several clinical and preclinical studies have shown that Carragelose forms a protective layer on the mucosa that prevents viruses from infecting cells. Laboratory and clinical data have demonstrated that Carragelose can also inhibit the spreading of SARS-CoV-2.^[1],[2] Marinomed is the holder of the IP rights and has licensed Carragelose for marketing in Europe, North America, Australia, and parts of Asia and Latin America. Marinomed’s portfolio of Carragelose-containing nasal sprays and oral products can be accessed at https://www.carragelose.com/en/portfolio/launched-products, scientific publications on Carragelose at https://www.carragelose.com/en/publications.